

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.08224559 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.71012794 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.71012794 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 7.51810108 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.38496856 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.38496856 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.90993410 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.64799752 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 6.53028502 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.20959922 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.20959922 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.20959922 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.05899888 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.94656926 |
| 15 | drug metabolic process (GO:0017144) | 5.88553401 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.84032596 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.77124684 |
| 18 | urea metabolic process (GO:0019627) | 5.75966044 |
| 19 | urea cycle (GO:0000050) | 5.75966044 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.67051697 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.62728857 |
| 22 | * high-density lipoprotein particle remodeling (GO:0034375) | 5.42564745 |
| 23 | cysteine metabolic process (GO:0006534) | 5.41584126 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.41011968 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.40922733 |
| 26 | protein carboxylation (GO:0018214) | 5.40469279 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.40469279 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.30025746 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.26467843 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.23980795 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.19506678 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 5.17453914 |
| 33 | oxidative demethylation (GO:0070989) | 5.16450342 |
| 34 | bile acid metabolic process (GO:0008206) | 5.11855546 |
| 35 | phenylpropanoid metabolic process (GO:0009698) | 5.05702211 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 5.02432799 |
| 37 | regulation of plasminogen activation (GO:0010755) | 4.99405422 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.89473234 |
| 39 | regulation of complement activation (GO:0030449) | 4.88041601 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86655635 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.82222741 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.82222741 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.75028138 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.69015516 |
| 45 | * macromolecular complex remodeling (GO:0034367) | 4.66586445 |
| 46 | * plasma lipoprotein particle remodeling (GO:0034369) | 4.66586445 |
| 47 | * protein-lipid complex remodeling (GO:0034368) | 4.66586445 |
| 48 | * reverse cholesterol transport (GO:0043691) | 4.65756130 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.60203662 |
| 50 | lysine metabolic process (GO:0006553) | 4.59215630 |
| 51 | lysine catabolic process (GO:0006554) | 4.59215630 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.52221123 |
| 53 | * acylglycerol homeostasis (GO:0055090) | 4.50734992 |
| 54 | * triglyceride homeostasis (GO:0070328) | 4.50734992 |
| 55 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.48639122 |
| 56 | intestinal cholesterol absorption (GO:0030299) | 4.46549495 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.45976504 |
| 58 | * regulation of triglyceride catabolic process (GO:0010896) | 4.45905551 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.45479019 |
| 60 | glycine metabolic process (GO:0006544) | 4.45085540 |
| 61 | negative regulation of coagulation (GO:0050819) | 4.40398818 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.39809778 |
| 63 | imidazole-containing compound metabolic process (GO:0052803) | 4.38081260 |
| 64 | alkaloid metabolic process (GO:0009820) | 4.37077392 |
| 65 | ethanol metabolic process (GO:0006067) | 4.34213792 |
| 66 | cellular glucuronidation (GO:0052695) | 4.33930951 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.31525914 |
| 68 | amine catabolic process (GO:0009310) | 4.31525914 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.31127125 |
| 70 | * phospholipid efflux (GO:0033700) | 4.30779857 |
| 71 | * negative regulation of sterol transport (GO:0032372) | 4.30098659 |
| 72 | * negative regulation of cholesterol transport (GO:0032375) | 4.30098659 |
| 73 | negative regulation of wound healing (GO:0061045) | 4.30045292 |
| 74 | glutamate metabolic process (GO:0006536) | 4.29420726 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 4.21482546 |
| 76 | * plasma lipoprotein particle clearance (GO:0034381) | 4.17803173 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 4.17357927 |
| 78 | acute-phase response (GO:0006953) | 4.17200978 |
| 79 | hormone catabolic process (GO:0042447) | 4.16151278 |
| 80 | heme transport (GO:0015886) | 4.14995393 |
| 81 | arginine metabolic process (GO:0006525) | 4.12122680 |
| 82 | ethanol oxidation (GO:0006069) | 4.11788534 |
| 83 | * protein-lipid complex assembly (GO:0065005) | 4.09676179 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.09642807 |
| 85 | * cholesterol efflux (GO:0033344) | 4.09323552 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 4.09030397 |
| 87 | S-adenosylmethionine metabolic process (GO:0046500) | 4.08387515 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 4.08049662 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06808752 |
| 90 | drug catabolic process (GO:0042737) | 4.06093154 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 4.04870119 |
| 92 | aldehyde catabolic process (GO:0046185) | 4.03768184 |
| 93 | fibrinolysis (GO:0042730) | 4.00870947 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.99530807 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.99530807 |
| 96 | positive regulation of blood coagulation (GO:0030194) | 3.98755289 |
| 97 | positive regulation of hemostasis (GO:1900048) | 3.98755289 |
| 98 | * plasma lipoprotein particle organization (GO:0071827) | 3.98246713 |
| 99 | * negative regulation of lipase activity (GO:0060192) | 3.95904323 |
| 100 | regulation of humoral immune response (GO:0002920) | 3.93912129 |
| 101 | ketone body metabolic process (GO:1902224) | 3.91539282 |
| 102 | * very-low-density lipoprotein particle assembly (GO:0034379) | 3.91361208 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.85214356 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.85214356 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.84959243 |
| 106 | cofactor catabolic process (GO:0051187) | 3.83382560 |
| 107 | blood coagulation, intrinsic pathway (GO:0007597) | 3.82870803 |
| 108 | negative regulation of protein activation cascade (GO:2000258) | 3.79682524 |
| 109 | organic acid catabolic process (GO:0016054) | 3.76988190 |
| 110 | carboxylic acid catabolic process (GO:0046395) | 3.76988190 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76381196 |
| 112 | * protein-lipid complex subunit organization (GO:0071825) | 3.75525118 |
| 113 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.75119185 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.75076238 |
| 115 | phospholipid homeostasis (GO:0055091) | 3.74480093 |
| 116 | * plasma lipoprotein particle assembly (GO:0034377) | 3.73819372 |
| 117 | complement activation (GO:0006956) | 3.69916969 |
| 118 | * cholesterol homeostasis (GO:0042632) | 3.69822583 |
| 119 | positive regulation of coagulation (GO:0050820) | 3.69635476 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.69120493 |
| 121 | protein activation cascade (GO:0072376) | 3.68921863 |
| 122 | acetyl-CoA metabolic process (GO:0006084) | 3.68738819 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 3.68107027 |
| 124 | * sterol homeostasis (GO:0055092) | 3.63660723 |
| 125 | cytolysis (GO:0019835) | 3.63214205 |
| 126 | flavonoid metabolic process (GO:0009812) | 3.62820567 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.61550337 |
| 128 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.57990429 |
| 129 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57990429 |
| 130 | opsonization (GO:0008228) | 3.54899336 |
| 131 | response to nitrosative stress (GO:0051409) | 3.53975530 |
| 132 | doxorubicin metabolic process (GO:0044598) | 3.50981179 |
| 133 | daunorubicin metabolic process (GO:0044597) | 3.50981179 |
| 134 | polyketide metabolic process (GO:0030638) | 3.50981179 |
| 135 | * lipoprotein metabolic process (GO:0042157) | 3.49537430 |
| 136 | intestinal absorption (GO:0050892) | 3.48177214 |
| 137 | drug transmembrane transport (GO:0006855) | 3.41414160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.40868946 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21167851 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.02852649 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48914325 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29759774 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.05045748 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.91624336 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03264057 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99233979 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06146079 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9766153 |
| 12 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96033039 |
| 13 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92338307 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58583922 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55630095 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54949268 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39800125 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37655519 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29015532 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27579124 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21727666 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19610932 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18105383 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14817293 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04920345 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03175462 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02090675 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97406041 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94189967 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93235624 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86080677 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86062028 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85530646 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83431382 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82744226 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82608902 |
| 37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82546800 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82185345 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81190328 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80191078 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79513333 |
| 42 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77667220 |
| 43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77252204 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.75009671 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74991946 |
| 46 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74587379 |
| 47 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74485191 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72985278 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72664576 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71033514 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70858233 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70446466 |
| 53 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.67281851 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67193494 |
| 55 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.67151303 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66883694 |
| 57 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.66422144 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66409516 |
| 59 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.65486082 |
| 60 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.65164082 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65006560 |
| 62 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64805201 |
| 63 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64500522 |
| 64 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.64368043 |
| 65 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64354881 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.64044266 |
| 67 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.63664919 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63242433 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63242433 |
| 70 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62850384 |
| 71 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62821317 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62782184 |
| 73 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60100444 |
| 74 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.58464367 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.58369376 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.57947530 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.57180864 |
| 78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57171331 |
| 79 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.57162746 |
| 80 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.56531051 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56504875 |
| 82 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.55451879 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55292818 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54784474 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54747135 |
| 86 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.54598184 |
| 87 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52940374 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52123053 |
| 89 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52099658 |
| 90 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51903308 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.51669017 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51509593 |
| 93 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.51098388 |
| 94 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.50537731 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50405293 |
| 96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50381017 |
| 97 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.49661039 |
| 98 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49335182 |
| 99 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48348880 |
| 100 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47376365 |
| 101 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47288055 |
| 102 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46916709 |
| 103 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45441303 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44483365 |
| 105 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44131121 |
| 106 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43338512 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.42771737 |
| 108 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42044587 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41307124 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41236248 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40941085 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40749235 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40626290 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40281037 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40134840 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39535972 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39510518 |
| 118 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38397083 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.38156940 |
| 120 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37927233 |
| 121 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37576838 |
| 122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37167788 |
| 123 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36707822 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.35342253 |
| 125 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35197970 |
| 126 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34670704 |
| 127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34557841 |
| 128 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33091303 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.32712501 |
| 130 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.32483819 |
| 131 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.32476761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.45963715 |
| 2 | MP0005360_urolithiasis | 7.67326564 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.45112359 |
| 4 | MP0005365_abnormal_bile_salt | 6.18734671 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.23189133 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.27507108 |
| 7 | MP0003252_abnormal_bile_duct | 3.92768689 |
| 8 | * MP0010329_abnormal_lipoprotein_level | 3.53836596 |
| 9 | MP0005083_abnormal_biliary_tract | 3.01033154 |
| 10 | MP0003195_calcinosis | 2.83886697 |
| 11 | MP0005332_abnormal_amino_acid | 2.78312401 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.68222135 |
| 13 | * MP0009840_abnormal_foam_cell | 2.56848725 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.36251231 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17259683 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.16756292 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.09737946 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.94327073 |
| 19 | MP0003868_abnormal_feces_composition | 1.91099892 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83481007 |
| 21 | MP0001764_abnormal_homeostasis | 1.68400930 |
| 22 | MP0009697_abnormal_copulation | 1.64014751 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58228057 |
| 24 | MP0005451_abnormal_body_composition | 1.51167564 |
| 25 | MP0003011_delayed_dark_adaptation | 1.41077058 |
| 26 | MP0003186_abnormal_redox_activity | 1.27057985 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.23744406 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.22594790 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.18028275 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17000212 |
| 31 | MP0005647_abnormal_sex_gland | 1.13064866 |
| 32 | MP0000604_amyloidosis | 1.11133308 |
| 33 | MP0009764_decreased_sensitivity_to | 1.06388455 |
| 34 | MP0009763_increased_sensitivity_to | 1.01453181 |
| 35 | MP0002254_reproductive_system_inflammat | 0.99341922 |
| 36 | MP0003879_abnormal_hair_cell | 0.93652456 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.92367640 |
| 38 | MP0010368_abnormal_lymphatic_system | 0.90913538 |
| 39 | MP0008469_abnormal_protein_level | 0.88766415 |
| 40 | * MP0009642_abnormal_blood_homeostasis | 0.86993946 |
| 41 | MP0005408_hypopigmentation | 0.83852595 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 0.83033018 |
| 43 | MP0005376_homeostasis/metabolism_phenot | 0.80895997 |
| 44 | MP0002132_abnormal_respiratory_system | 0.80032505 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.79588263 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.79132428 |
| 47 | MP0003183_abnormal_peptide_metabolism | 0.78326031 |
| 48 | MP0005670_abnormal_white_adipose | 0.76051483 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 0.75983635 |
| 50 | * MP0002078_abnormal_glucose_homeostasis | 0.75523456 |
| 51 | MP0000566_synostosis | 0.73228543 |
| 52 | MP0002971_abnormal_brown_adipose | 0.72422494 |
| 53 | MP0005334_abnormal_fat_pad | 0.70109375 |
| 54 | MP0003690_abnormal_glial_cell | 0.68753681 |
| 55 | MP0009053_abnormal_anal_canal | 0.68048879 |
| 56 | MP0004264_abnormal_extraembryonic_tissu | 0.67977615 |
| 57 | MP0001915_intracranial_hemorrhage | 0.67890356 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.67885007 |
| 59 | MP0005535_abnormal_body_temperature | 0.66873889 |
| 60 | MP0005266_abnormal_metabolism | 0.66516394 |
| 61 | MP0003329_amyloid_beta_deposits | 0.65526268 |
| 62 | MP0004130_abnormal_muscle_cell | 0.65390966 |
| 63 | MP0001661_extended_life_span | 0.63228938 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.60930030 |
| 65 | MP0001756_abnormal_urination | 0.58015722 |
| 66 | MP0002822_catalepsy | 0.57880150 |
| 67 | MP0005409_darkened_coat_color | 0.56328092 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.55928982 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.51986497 |
| 70 | MP0005395_other_phenotype | 0.48743863 |
| 71 | MP0003718_maternal_effect | 0.48463063 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.48195361 |
| 73 | MP0005023_abnormal_wound_healing | 0.48067985 |
| 74 | MP0005187_abnormal_penis_morphology | 0.46787424 |
| 75 | MP0008874_decreased_physiological_sensi | 0.46742638 |
| 76 | * MP0005448_abnormal_energy_balance | 0.46354113 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.46338972 |
| 78 | MP0008873_increased_physiological_sensi | 0.46153828 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.44719843 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.42889038 |
| 81 | MP0005248_abnormal_Harderian_gland | 0.42591830 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 0.42250185 |
| 83 | MP0003878_abnormal_ear_physiology | 0.41963241 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.41963241 |
| 85 | MP0002928_abnormal_bile_duct | 0.41882346 |
| 86 | MP0003075_altered_response_to | 0.41813289 |
| 87 | MP0003436_decreased_susceptibility_to | 0.41657192 |
| 88 | MP0003724_increased_susceptibility_to | 0.40545719 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.40043117 |
| 90 | * MP0003953_abnormal_hormone_level | 0.39039013 |
| 91 | MP0008872_abnormal_physiological_respon | 0.39007327 |
| 92 | MP0005166_decreased_susceptibility_to | 0.38919334 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.36700636 |
| 94 | MP0004381_abnormal_hair_follicle | 0.36105502 |
| 95 | MP0009672_abnormal_birth_weight | 0.35698501 |
| 96 | MP0009785_altered_susceptibility_to | 0.34909061 |
| 97 | MP0002796_impaired_skin_barrier | 0.34663914 |
| 98 | MP0009115_abnormal_fat_cell | 0.34203858 |
| 99 | MP0002249_abnormal_larynx_morphology | 0.33342329 |
| 100 | MP0000579_abnormal_nail_morphology | 0.32977443 |
| 101 | MP0006082_CNS_inflammation | 0.32959869 |
| 102 | MP0001243_abnormal_dermal_layer | 0.31965827 |
| 103 | MP0004883_abnormal_blood_vessel | 0.31748673 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.31119405 |
| 105 | MP0002168_other_aberrant_phenotype | 0.30088006 |
| 106 | MP0001853_heart_inflammation | 0.28826444 |
| 107 | MP0001881_abnormal_mammary_gland | 0.28744544 |
| 108 | MP0002282_abnormal_trachea_morphology | 0.28693483 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.28343744 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.27962068 |
| 111 | MP0004147_increased_porphyrin_level | 0.27433624 |
| 112 | * MP0000249_abnormal_blood_vessel | 0.26985006 |
| 113 | MP0000920_abnormal_myelination | 0.26925629 |
| 114 | MP0001986_abnormal_taste_sensitivity | 0.25940782 |
| 115 | MP0005164_abnormal_response_to | 0.24937090 |
| 116 | MP0002090_abnormal_vision | 0.23921428 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.23847995 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.22754435 |
| 119 | * MP0002970_abnormal_white_adipose | 0.22652684 |
| 120 | MP0002060_abnormal_skin_morphology | 0.22481706 |
| 121 | MP0003632_abnormal_nervous_system | 0.21427768 |
| 122 | MP0004272_abnormal_basement_membrane | 0.19884187 |
| 123 | MP0002135_abnormal_kidney_morphology | 0.19631888 |
| 124 | MP0003959_abnormal_lean_body | 0.17408752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.57991787 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.45635537 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.26031108 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.81750830 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.56601619 |
| 6 | Xanthomatosis (HP:0000991) | 6.34025073 |
| 7 | * Hypobetalipoproteinemia (HP:0003563) | 5.85154208 |
| 8 | Complement deficiency (HP:0004431) | 5.23476306 |
| 9 | * Hyperlipoproteinemia (HP:0010980) | 4.83575302 |
| 10 | Joint hemorrhage (HP:0005261) | 4.80731923 |
| 11 | Hyperammonemia (HP:0001987) | 4.66047603 |
| 12 | Epidermoid cyst (HP:0200040) | 4.49967626 |
| 13 | * Hypolipoproteinemia (HP:0010981) | 4.45661985 |
| 14 | Hyperglycinemia (HP:0002154) | 4.44813223 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.41188014 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.33629992 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.31558456 |
| 18 | Ketosis (HP:0001946) | 4.29209190 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.26341239 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.22922665 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18935432 |
| 22 | Fat malabsorption (HP:0002630) | 4.14200878 |
| 23 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09873683 |
| 24 | Hyperglycinuria (HP:0003108) | 3.98976590 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95494323 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.95494323 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.90623774 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.89552195 |
| 29 | Abnormality of complement system (HP:0005339) | 3.81832086 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75868934 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72369468 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.65460152 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.43255942 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.38796723 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.35889383 |
| 36 | Delayed CNS myelination (HP:0002188) | 3.12583055 |
| 37 | Steatorrhea (HP:0002570) | 3.11866253 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11332654 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.09185184 |
| 40 | Ketoacidosis (HP:0001993) | 3.03806272 |
| 41 | Spontaneous abortion (HP:0005268) | 3.00468511 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.96375265 |
| 43 | Myocardial infarction (HP:0001658) | 2.94505509 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.93897157 |
| 45 | Metabolic acidosis (HP:0001942) | 2.82037008 |
| 46 | Skin nodule (HP:0200036) | 2.76938516 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.71687094 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.68791645 |
| 49 | Osteomalacia (HP:0002749) | 2.66358612 |
| 50 | Lethargy (HP:0001254) | 2.64377855 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.62635127 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62635127 |
| 53 | Vascular calcification (HP:0004934) | 2.61337006 |
| 54 | Acanthocytosis (HP:0001927) | 2.54440594 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.51136291 |
| 56 | Glycosuria (HP:0003076) | 2.51136291 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.49911274 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.49587478 |
| 59 | Spastic diplegia (HP:0001264) | 2.47573326 |
| 60 | Cholecystitis (HP:0001082) | 2.47380813 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.47380813 |
| 62 | Cerebral edema (HP:0002181) | 2.44535105 |
| 63 | Cholelithiasis (HP:0001081) | 2.43985026 |
| 64 | Mitral stenosis (HP:0001718) | 2.42913384 |
| 65 | Gout (HP:0001997) | 2.42814870 |
| 66 | Purpura (HP:0000979) | 2.41766271 |
| 67 | Glomerulonephritis (HP:0000099) | 2.39956213 |
| 68 | Irritability (HP:0000737) | 2.38405613 |
| 69 | Malnutrition (HP:0004395) | 2.38038007 |
| 70 | Amyloidosis (HP:0011034) | 2.36318253 |
| 71 | Neonatal onset (HP:0003623) | 2.35838871 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.35227620 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.31602057 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26608845 |
| 75 | Esophageal varix (HP:0002040) | 2.19817699 |
| 76 | Late onset (HP:0003584) | 2.18950751 |
| 77 | Gingival bleeding (HP:0000225) | 2.18290618 |
| 78 | Brushfield spots (HP:0001088) | 2.16652730 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.16639175 |
| 80 | Pancreatitis (HP:0001733) | 2.16381421 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.15766424 |
| 82 | Menorrhagia (HP:0000132) | 2.15414611 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.13223246 |
| 84 | Vomiting (HP:0002013) | 2.10401966 |
| 85 | Enlarged kidneys (HP:0000105) | 2.10069168 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 2.09809713 |
| 87 | Pulmonary embolism (HP:0002204) | 2.07140009 |
| 88 | Thrombophlebitis (HP:0004418) | 2.07097522 |
| 89 | Opisthotonus (HP:0002179) | 2.05344909 |
| 90 | Joint swelling (HP:0001386) | 2.04548803 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.03554556 |
| 92 | Abnormal urine phosphate concentration (HP:0012599) | 2.03309567 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03059491 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 2.03032163 |
| 95 | Poikilocytosis (HP:0004447) | 2.01231993 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.00234817 |
| 97 | Arthropathy (HP:0003040) | 1.98783548 |
| 98 | Rickets (HP:0002748) | 1.94546606 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 1.94285473 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.93169485 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 1.93169485 |
| 102 | Retinal atrophy (HP:0001105) | 1.93085456 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91050574 |
| 104 | Abnormal cartilage morphology (HP:0002763) | 1.90762801 |
| 105 | Pigmentary retinal degeneration (HP:0001146) | 1.90379607 |
| 106 | Increased serum ferritin (HP:0003281) | 1.90300698 |
| 107 | Hypophosphatemic rickets (HP:0004912) | 1.88715599 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.88322888 |
| 109 | Renal cortical cysts (HP:0000803) | 1.84521207 |
| 110 | Nausea (HP:0002018) | 1.84268767 |
| 111 | Alkalosis (HP:0001948) | 1.83647499 |
| 112 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82139314 |
| 113 | Fair hair (HP:0002286) | 1.81928772 |
| 114 | Elevated hepatic transaminases (HP:0002910) | 1.81148948 |
| 115 | Status epilepticus (HP:0002133) | 1.80962868 |
| 116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79310786 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 1.79025769 |
| 118 | Bifid scrotum (HP:0000048) | 1.78990093 |
| 119 | Epistaxis (HP:0000421) | 1.73688835 |
| 120 | Reticulocytosis (HP:0001923) | 1.73075031 |
| 121 | Nephritis (HP:0000123) | 1.72858868 |
| 122 | Hypophosphatemia (HP:0002148) | 1.72056405 |
| 123 | Facial shape deformation (HP:0011334) | 1.71812855 |
| 124 | Potter facies (HP:0002009) | 1.71812855 |
| 125 | Widely patent fontanelles and sutures (HP:0004492) | 1.67611816 |
| 126 | Nephrolithiasis (HP:0000787) | 1.67154372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.26799791 |
| 2 | FGFR4 | 4.62219320 |
| 3 | SIK1 | 4.60074329 |
| 4 | ERN1 | 4.55138742 |
| 5 | MUSK | 3.75402117 |
| 6 | ACVR1B | 3.46114678 |
| 7 | TAOK3 | 3.01895852 |
| 8 | INSRR | 2.81580911 |
| 9 | ERBB4 | 2.76377247 |
| 10 | PDK2 | 2.63566516 |
| 11 | TESK2 | 2.34584985 |
| 12 | MAP2K4 | 2.34051129 |
| 13 | PKN2 | 2.25912091 |
| 14 | MAP3K12 | 2.16765548 |
| 15 | MST1R | 2.14209151 |
| 16 | FLT3 | 1.92335659 |
| 17 | PIK3CG | 1.80362403 |
| 18 | MAPK11 | 1.80053617 |
| 19 | TRIB3 | 1.77561015 |
| 20 | PIK3CA | 1.70679343 |
| 21 | TYK2 | 1.67734282 |
| 22 | LATS1 | 1.62331811 |
| 23 | MAP3K2 | 1.55578849 |
| 24 | DAPK2 | 1.52259277 |
| 25 | ABL2 | 1.51080318 |
| 26 | PTK6 | 1.50461962 |
| 27 | FRK | 1.45970640 |
| 28 | NEK9 | 1.35380237 |
| 29 | PRPF4B | 1.34159080 |
| 30 | FGFR2 | 1.32293439 |
| 31 | KDR | 1.30284151 |
| 32 | MYLK | 1.22371188 |
| 33 | JAK2 | 1.18999530 |
| 34 | MAP3K7 | 1.18938090 |
| 35 | GRK6 | 1.18367163 |
| 36 | NTRK3 | 1.13154947 |
| 37 | PINK1 | 1.12966873 |
| 38 | PRKAA2 | 1.11515007 |
| 39 | TBK1 | 1.10315743 |
| 40 | PRKG2 | 1.10127561 |
| 41 | EPHA2 | 1.08451195 |
| 42 | MAP2K3 | 1.07213217 |
| 43 | NLK | 1.02127292 |
| 44 | MAP3K10 | 0.99882423 |
| 45 | MAPK4 | 0.98550607 |
| 46 | JAK1 | 0.97534807 |
| 47 | MAP3K14 | 0.96532470 |
| 48 | ERBB2 | 0.96118164 |
| 49 | PRKCZ | 0.93204845 |
| 50 | MAP3K3 | 0.91183213 |
| 51 | MAPK15 | 0.90147847 |
| 52 | PDGFRA | 0.86598244 |
| 53 | MAP3K11 | 0.86100993 |
| 54 | MET | 0.85198368 |
| 55 | STK38L | 0.84819519 |
| 56 | EPHB1 | 0.83191452 |
| 57 | CDK6 | 0.82440301 |
| 58 | LMTK2 | 0.81928469 |
| 59 | MAPK12 | 0.79636942 |
| 60 | PRKACG | 0.76101931 |
| 61 | MAP2K6 | 0.75294818 |
| 62 | TIE1 | 0.74122197 |
| 63 | DYRK1B | 0.73117431 |
| 64 | CAMK2G | 0.72688228 |
| 65 | CSK | 0.72594772 |
| 66 | EPHA3 | 0.70429901 |
| 67 | GSK3A | 0.68484722 |
| 68 | IRAK3 | 0.66081295 |
| 69 | RIPK1 | 0.65151193 |
| 70 | CAMK1D | 0.64711932 |
| 71 | KSR2 | 0.63863332 |
| 72 | PRKAA1 | 0.63162748 |
| 73 | SGK3 | 0.60537882 |
| 74 | PTK2 | 0.58790771 |
| 75 | FER | 0.58031010 |
| 76 | PRKACA | 0.57721051 |
| 77 | PRKG1 | 0.57555606 |
| 78 | MAPK7 | 0.56692567 |
| 79 | IKBKE | 0.56308286 |
| 80 | FGFR1 | 0.55634233 |
| 81 | TGFBR2 | 0.54777258 |
| 82 | PDPK1 | 0.53575822 |
| 83 | CSF1R | 0.53001424 |
| 84 | PRKCQ | 0.52852674 |
| 85 | FGFR3 | 0.52406268 |
| 86 | CSNK1G1 | 0.52192133 |
| 87 | EPHA4 | 0.51404763 |
| 88 | TAOK2 | 0.49889298 |
| 89 | WNK3 | 0.47234103 |
| 90 | MAP2K1 | 0.45308782 |
| 91 | PRKCB | 0.45238463 |
| 92 | CSNK1D | 0.44888158 |
| 93 | MAP3K5 | 0.44768648 |
| 94 | GRK1 | 0.44549207 |
| 95 | SRC | 0.44192507 |
| 96 | MAP3K13 | 0.42721851 |
| 97 | IGF1R | 0.42180359 |
| 98 | SGK2 | 0.41330607 |
| 99 | CDK4 | 0.41261421 |
| 100 | PRKACB | 0.41150041 |
| 101 | ICK | 0.40388297 |
| 102 | PRKCG | 0.40220735 |
| 103 | RET | 0.39889577 |
| 104 | PIM2 | 0.38694986 |
| 105 | ZAP70 | 0.38450246 |
| 106 | PBK | 0.38224340 |
| 107 | TNIK | 0.38167539 |
| 108 | MAP3K6 | 0.37406519 |
| 109 | CAMK4 | 0.34209446 |
| 110 | CSNK1G2 | 0.33468142 |
| 111 | MATK | 0.33056106 |
| 112 | MTOR | 0.32846366 |
| 113 | PDK1 | 0.32424061 |
| 114 | CSNK1G3 | 0.32404690 |
| 115 | EGFR | 0.32111679 |
| 116 | MAPKAPK3 | 0.32102987 |
| 117 | PKN1 | 0.30967956 |
| 118 | SGK1 | 0.30838605 |
| 119 | MAP2K2 | 0.30836461 |
| 120 | MAP3K1 | 0.29831326 |
| 121 | SGK494 | 0.29261394 |
| 122 | SGK223 | 0.29261394 |
| 123 | RPS6KA3 | 0.28878163 |
| 124 | CSNK2A1 | 0.28587703 |
| 125 | LATS2 | 0.27730147 |
| 126 | CSNK2A2 | 0.27334182 |
| 127 | CSNK1E | 0.27142855 |
| 128 | SCYL2 | 0.27010409 |
| 129 | CDK12 | 0.26678082 |
| 130 | PRKCA | 0.26366193 |
| 131 | IRAK2 | 0.24806660 |
| 132 | BMX | 0.24132256 |
| 133 | AKT3 | 0.23647903 |
| 134 | CSNK1A1L | 0.23253515 |
| 135 | IRAK1 | 0.21823546 |
| 136 | PAK3 | 0.20879951 |
| 137 | PDK3 | 0.20764545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47918453 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49641754 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39814826 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37530883 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09041445 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70546613 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70452623 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68837703 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61935809 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52766450 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46758337 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36844482 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27975356 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18764019 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12841240 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07609667 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99747658 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98043939 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94500046 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92116250 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90372472 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79686824 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79586122 |
| 24 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79414053 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78965304 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73814072 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73757643 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71513595 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69217329 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66088920 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61086723 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56906736 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56811812 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52347801 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51384370 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.51100799 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44507316 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38968662 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36881861 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33302086 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32926009 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31429510 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26789451 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24084424 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21209023 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18404703 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.17084235 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13107886 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03239444 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02090461 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01801735 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97653180 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97317593 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95916859 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89513459 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89241222 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88517225 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85829252 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79356272 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74195022 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70958119 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68365688 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67944476 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58963928 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53458205 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.51652115 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49111894 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47338758 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46279266 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.34486947 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31722262 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28920611 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27531753 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25601622 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23035698 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.22446190 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.21824417 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20532869 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19222687 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16830039 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15246272 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09706095 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08490430 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00969322 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2461732 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2442222 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2440214 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2369221 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2276283 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2023488 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1878232 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1862811 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1841294 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1838991 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1733149 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1682264 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1617451 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1519351 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1478371 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1320459 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1305261 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1213273 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1078443 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1023184 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1003609 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0731767 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0675585 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0301621 |

